The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism

被引:558
作者
Veech, RL [1 ]
机构
[1] NIAAA, Lab Membrane Biochem & Biophys, Rockville, MD 20850 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2004年 / 70卷 / 03期
关键词
D O I
10.1016/j.plefa.2003.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of ketone body metabolism suggests that mild ketosis may offer therapeutic potential in a variety of different common and rare disease states. These inferences follow directly from the metabolic effects of ketosis and the higher inherent energy present in D-beta-hydroxybutyrate relative to pyruvate, the normal mitochondrial fuel produced by glycolysis leading to an increase in the DeltaG' of ATP hydrolysis. The large categories of disease for which ketones may have therapeutic effects are: (1) diseases of substrate insufficiency or insulin resistance, (2) diseases resulting from free radical damage, (3) disease resulting from hypoxia. Current ketogenic diets are all characterized by elevations of free fatty acids, which may lead to metabolic inefficiency by activation of the PPAR system and its associated uncoupling mitochondrial uncoupling proteins. New diets comprised of ketone bodies themselves or their esters may obviate this present difficulty. Published by Elsevier Ltd.
引用
收藏
页码:309 / 319
页数:11
相关论文
共 76 条
[51]  
NEBELING LC, 1995, J AM COLL NUTR, V14, P202
[52]   BRAIN METABOLISM DURING FASTING [J].
OWEN, OE ;
MORGAN, AP ;
KEMP, HG ;
SULLIVAN, JM ;
HERRERA, MG ;
CAHILL, GF .
JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (10) :1589-&
[53]  
POPE A, 1965, T AM NEUROL ASSOC, V89, P15
[54]   KETONE-BODY PRODUCTION AND OXIDATION IN FASTING OBESE HUMANS [J].
REICHARD, GA ;
OWEN, OE ;
HAFF, AC ;
PAUL, P ;
BORTZ, WM .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (02) :508-515
[55]   Frataxin activates mitochondrial energy conversion and oxidative phosphorylation [J].
Ristow, M ;
Pfister, MF ;
Yee, AJ ;
Schubert, M ;
Michael, L ;
Zhang, CY ;
Ueki, K ;
Michael, MD ;
Lowell, BB ;
Kahn, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12239-12243
[56]   A NOVEL HUMAN INSULIN-RECEPTOR GENE MUTATION UNIQUELY INHIBITS INSULIN BINDING WITHOUT IMPAIRING POSTTRANSLATIONAL PROCESSING [J].
ROACH, P ;
ZICK, Y ;
FORMISANO, P ;
ACCILI, D ;
TAYLOR, SI ;
GORDEN, P .
DIABETES, 1994, 43 (09) :1096-1102
[57]   Cognitive enhancers in theory and practice: Studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease [J].
Robbins, TW ;
McAlonan, G ;
Muir, JL ;
Everitt, BJ .
BEHAVIOURAL BRAIN RESEARCH, 1997, 83 (1-2) :15-23
[58]   INSULIN, KETONE-BODIES, AND MITOCHONDRIAL ENERGY TRANSDUCTION [J].
SATO, K ;
KASHIWAYA, Y ;
KEON, CA ;
TSUCHIYA, N ;
KING, MT ;
RADDA, GK ;
CHANCE, B ;
CLARKE, K ;
VEECH, RL .
FASEB JOURNAL, 1995, 9 (08) :651-658
[59]   ISOLATION AND H-1-NMR SPECTROSCOPIC IDENTIFICATION OF POLY(3-HYDROXYBUTANOATE) FROM PROKARYOTIC AND EUKARYOTIC ORGANISMS - DETERMINATION OF THE ABSOLUTE-CONFIGURATION (R) OF THE MONOMERIC UNIT 3-HYDROXYBUTANOIC ACID FROM ESCHERICHIA-COLI AND SPINACH [J].
SEEBACH, D ;
BRUNNER, A ;
BURGER, HM ;
SCHNEIDER, J ;
REUSCH, RN .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02) :317-328
[60]   Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. [J].
Seshadri, S ;
Beiser, A ;
Selhub, J ;
Jacques, PF ;
Rosenberg, IH ;
D'Agostino, RB ;
Wilson, PWF ;
Wolf, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) :476-483